Jensterle, Mojca

Efficacy of GLP-1 RA Approved for Weight Management in Patients With or Without Diabetes: A Narrative Review

Jensterle, M., Rizzo, M., Haluzík, M., & Janež, A. (2022) · Advances in Therapy

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 215

Liraglutide increases IVF pregnancy rates in obese PCOS women with poor response to first-line reproductive treatments: a pilot randomized study

Salamun, V., Jensterle, M., Janez, A., & Vrtacnik Bokal, E. (2018) · European Journal of Endocrinology

Ovarian function and disordersReproductive Health and Technologies

Cited by 204

A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome

Jensterle, M., Kravos, N. A., Pfeifer, M., Kocjan, T., & Janez, A. (2015) · Hormones

Ovarian function and disordersPharmacology and Obesity Treatment

Cited by 117

Short term monotherapy with GLP-1 receptor agonist liraglutide or PDE 4 inhibitor roflumilast is superior to metformin in weight loss in obese PCOS women: a pilot randomized study

Jensterle, M., Salamun, V., Kocjan, T., Vrtacnik Bokal, E., & Janez, A. (2015) · Journal of Ovarian Research

Ovarian function and disordersPharmacology and Obesity Treatment

Cited by 103

Semaglutide delays 4‐hour gastric emptying in women with polycystic ovary syndrome and obesity

Jensterle, M., Ferjan, S., Ležaič, L., Sočan, A., Goričar, K., Zaletel, K., & Janez, A. (2023) · Diabetes, Obesity and Metabolism

Gastrointestinal motility and disordersDiabetes Treatment and Management

Cited by 102

Effects of liraglutide on obesity-associated functional hypogonadism in men

Jensterle, M., Podbregar, A., Goricar, K., Gregoric, N., & Janez, A. (2019) · Endocrine Connections

Hormonal and reproductive studiesHypothalamic control of reproductive hormones

Cited by 101

Short-term effectiveness of low dose liraglutide in combination with metformin versus high dose liraglutide alone in treatment of obese PCOS: randomized trial

Jensterle, M., Kravos, N. A., Goričar, K., & Janez, A. (2017) · BMC Endocrine Disorders

Ovarian function and disordersPharmacology and Obesity Treatment

Cited by 93

Short-Term Intervention with Liraglutide Improved Eating Behavior in Obese Women with Polycystic Ovary Syndrome

Jensterle, M., Kocjan, T., Kravos, N. A., Pfeifer, M., & Janez, A. (2015) · Endocrine Research

Ovarian function and disordersEating Disorders and Behaviors

Cited by 86

Genetic variability in GLP-1 receptor is associated with inter-individual differences in weight lowering potential of liraglutide in obese women with PCOS: a pilot study

Jensterle, M., Pirš, B., Goričar, K., Dolžan, V., & Janež, A. (2015) · European Journal of Clinical Pharmacology

Ovarian function and disordersPharmacology and Obesity Treatment

Cited by 86

Insulin Metabolism in Polycystic Ovary Syndrome: Secretion, Signaling, and Clearance

Herman, R., Sikonja, J., Jensterle, M., Janez, A., & Dolzan, V. (2023) · International Journal of Molecular Sciences

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 69

Metformin as an initial adjunct to low-dose liraglutide enhances the weight-decreasing potential of liraglutide in obese polycystic ovary syndrome: Randomized control study

JENSTERLE, M., GORICAR, K., & JANEZ, A. (2016) · Experimental and Therapeutic Medicine

Ovarian function and disordersPharmacology and Obesity Treatment

Cited by 56

Therapeutic Potential of Glucagon-like Peptide-1 Agonists in Polycystic Ovary Syndrome: From Current Clinical Evidence to Future Perspectives

Jensterle, M., Herman, R., & Janež, A. (2022) · Biomedicines

Ovarian function and disordersPharmacology and Obesity Treatment

Cited by 50

Semaglutide reduces fat accumulation in the tongue: A randomized single-blind, pilot study

Jensterle, M., Ferjan, S., Vovk, A., Battelino, T., Rizzo, M., & Janež, A. (2021) · Diabetes Research and Clinical Practice

Diabetes Treatment and ManagementOvarian function and disorders

Cited by 49

Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.

Jensterle, M., Janez, A., Mlinar, B., Marc, J., Prezelj, J., & Pfeifer, M. (2008) · European Journal of Endocrinology

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 47

Brown Adipose Tissue: A New Potential Target for Glucagon-like Peptide 1 Receptor Agonists in the Treatment of Obesity

Hropot, T., Herman, R., Janez, A., Lezaic, L., & Jensterle, M. (2023) · International Journal of Molecular Sciences

Adipose Tissue and MetabolismPharmacology and Obesity Treatment

Cited by 39

Semaglutide and Taste in Women With Obesity and Polycystic Ovary Syndrome: A Randomized Placebo-Controlled Study

Jensterle, M., Kovac, J., Vovk, A., Ferjan, S., Battelino, S., Battelino, T., & Janez, A. (2025) · The Journal of Clinical Endocrinology & Metabolism

Biochemical Analysis and Sensing TechniquesOlfactory and Sensory Function Studies

Cited by 12